The Concord Biotech IPO made a significant mark in the financial market, opening for subscription between August 4 and August 8, 2023. With a price band set at ₹705-₹741 per share, the IPO was oversubscribed 24.87 times, raising approximately ₹1,551 crores. The shares were allotted on August 11, 2023, and listed on the BSE and NSE on August 18, 2023, at an impressive opening price of ₹900.05—a gain of 21.46% over the upper allotment price. The latest Grey Market Premium (GMP) stood at ₹122, reflecting strong investor sentiment around the stock.
Key Concord Biotech IPO Details
IPO Overview
- IPO Opening Date: August 4, 2023
- IPO Closing Date: August 8, 2023
- Concord Biotech IPO Allotment Price: ₹741
- Listing Date: August 18, 2023
- Price Band: ₹705 to ₹741 per share
- Issue Size: ₹1,551 crores
- Lot Size: Minimum of 20 shares (Total minimum investment: ₹14,820)
Subscription and Allotment
The Concord Biotech IPO allotment status revealed a robust demand from all categories of investors:
- Qualified Institutional Buyers (QIBs): 50%
- Non-Institutional Investors (NIIs): 15%
- Retail Investors: 35%
The IPO was oversubscribed by 24.87 times overall.
- Basis of Allotment Announced: August 11, 2023
- Refunds Initiated: August 14, 2023
- Shares Credited to Demat Accounts: August 17, 2023
Investors looking to check their Concord IPO allotment status could do so through the official registrar’s website or their respective broker.
Concord Biotech IPO Listing Performance
The listing day performance of the Concord Biotech IPO was remarkable:
- Listing Price: ₹900.05
- Percentage Gain on Listing Day: +21.46%
- Current Price (as of latest data): ₹1463.5
The sharp rise in the stock’s price since its debut demonstrates its strong market reception and investor confidence. Investors keen on Concord IPO review noted its stellar performance.
Concord Biotech IPO GMP Analysis
The Concord Biotech IPO GMP (Grey Market Premium) was last reported at ₹122. GMP is a crucial indicator of market sentiment before the Concord Biotech IPO listing date. The positive GMP suggests that investors had high expectations for the stock’s performance.
Why Concord Biotech IPO Stands Out
Strong Oversubscription
The IPO was oversubscribed 24.87 times, reflecting widespread demand among institutional and retail investors.
Impressive Listing Performance
The Concord Biotech IPO allotment price was set at the higher end of the price band (₹741), but the stock debuted at ₹900.05 on August 18, 2023. This 21.46% gain highlighted the company’s strong fundamentals and investor confidence.
Financial Stability
Concord Biotech is a well-established name in the biopharma sector, known for its robust financials and market presence. Such stability attracts both retail and institutional investors.
How to Analyze IPOs Like Concord Biotech
Investing in IPOs requires a deep understanding of various factors such as allotment status, GMP, price trends, and market performance. At GRM IIT, we specialize in teaching these analytical skills through our courses and resources. Whether you’re a beginner or an experienced investor, we help you make smarter financial decisions.
If you want to learn how to analyze IPOs like Concord Biotech or even better, contact us or visit our website at GRM IIT. We also offer free resources on our YouTube channel.
What You Need to Know Before Investing in IPOs
Investing in IPOs like Concord Biotech requires careful evaluation of key details:
- Allotment Price: Know the issue price range and make informed bids.
- Listing Date: Stay updated about the listing timeline.
- GMP: Monitor the Grey Market Premium for market sentiment.
- Market Performance: Keep an eye on the listing day gains and subsequent trends.
By understanding these factors, you can make better investment decisions and avoid losses. The Concord Biotech IPO details offer valuable insights into such processes.
Why Choose GRM Bulls?
At GRM Bulls, we provide comprehensive financial services and assistance to help you navigate the complexities of the stock market. From creating a Demat account to offering expert guidance, we’re here to support your investment journey.
Call-to-Action
If you want to create your Demat account and explore exciting investment opportunities like Concord Biotech IPO, click the button below:
Want to master trading and investment strategies? Visit GRM IIT for in-depth courses and expert training. Don’t miss out—invest in your financial future today!
Concord Biotech IPO FAQs
1. What is the Concord Biotech IPO allotment price?
The allotment price for the Concord Biotech IPO was set at the upper end of the price band, which is ₹741 per share.
2. What was the Concord Biotech IPO listing date?
The IPO shares were listed on the BSE and NSE on August 18, 2023.
3. How can I check the Concord Biotech IPO allotment status?
To check the allotment status, visit the official registrar website or consult your broker to confirm the allotment details.
4. What was the Concord IPO GMP during the IPO?
The last reported Grey Market Premium (GMP) for the Concord IPO was ₹122, indicating strong investor interest.
5. What is the minimum investment required for the Concord Biotech IPO?
Investors were required to bid for a minimum lot size of 20 shares, making the minimum investment ₹14,820 at the upper price band.
6. Is investing in Concord Biotech a good decision?
Concord Biotech has shown a 21.46% listing gain, and its current price trends suggest long-term growth in the biopharma sector. However, it’s advised to analyze further before investing.
